Teijo Pellinen

19PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 18, 2025
Validation of fibroblast activation protein and α-smooth muscle actin as prognostic biomarkers in prostate cancer through AI-assisted image analysis of dual-marker IHC.

Jenni Säilä, Timo-Pekka Lehto, Antti Rannikko

|Aug 07, 2025
Spatial Analysis of the Tumor Microenvironment in Diffuse Large B-cell Lymphoma Reveals Clinically Relevant Cell Interactions and Recurrent Cellular Neighborhoods.

Matias Autio, Suvi-Katri Leivonen, Leo Meriranta

|Feb 05, 2025
The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial.

Matthew Stephen Block, James Hugo Armstrong Clubb, Johanna Mäenpää

|Oct 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Matilda Roos-Mattila, Pauliina Kallio, Tamara J Luck

|Apr 22, 2024
Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma.

Jaakko S Knuutila, Pilvi Riihilä, Liisa Nissinen

|Mar 28, 2024
Safety, Efficacy, and Biological Data of T-Cell-Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial.

Santeri A Pakola, Katriina J Peltola, James H A Clubb

Pageof 4

Frequent Collaborators

3 joint publications

Sirpa Leppä

3 joint publications

Suvi-Katri Leivonen

3 joint publications

Riku Turkki

2 joint publications

Lyna Haybout